Literature DB >> 25907557

The Us3 Protein of Herpes Simplex Virus 1 Inhibits T Cell Signaling by Confining Linker for Activation of T Cells (LAT) Activation via TRAF6 Protein.

Yin Yang1, Songfang Wu1, Yu Wang1, Shuang Pan1, Bei Lan1, Yaohui Liu1, Liming Zhang1, Qianli Leng1, Da Chen1, Cuizhu Zhang2, Bin He3, Youjia Cao4.   

Abstract

Herpes simplex virus 1 (HSV-1) is the most prevalent human virus and causes global morbidity because the virus is able to infect multiple cell types. Remarkably, HSV infection switches between lytic and latent cycles, where T cells play a critical role. However, the precise way of virus-host interactions is incompletely understood. Here we report that HSV-1 productively infected Jurkat T-cells and inhibited antigen-induced T cell receptor activation. We discovered that HSV-1-encoded Us3 protein interrupted TCR signaling and interleukin-2 production by inactivation of the linker for activation of T cells. This study unveils a mechanism by which HSV-1 intrudes into early events of TCR-mediated cell signaling and may provide novel insights into HSV infection, during which the virus escapes from host immune surveillance.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  HSV-1; LAT; TCR; TRAF6; Us3; interleukin; signaling; ubiquitination

Mesh:

Substances:

Year:  2015        PMID: 25907557      PMCID: PMC4505477          DOI: 10.1074/jbc.M115.646422

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  47 in total

1.  The gamma 1 34.5 protein of herpes simplex virus 1 is required to interfere with dendritic cell maturation during productive infection.

Authors:  Huali Jin; Yijie Ma; Bellur S Prabhakar; Zongdi Feng; Tibor Valyi-Nagy; Zhipeng Yan; Dustin Verpooten; Cuizhu Zhang; Youjia Cao; Bin He
Journal:  J Virol       Date:  2009-03-11       Impact factor: 5.103

2.  Constitutive mTORC1 activation by a herpesvirus Akt surrogate stimulates mRNA translation and viral replication.

Authors:  Uyanga Chuluunbaatar; Richard Roller; Morris E Feldman; Stuart Brown; Kevan M Shokat; Ian Mohr
Journal:  Genes Dev       Date:  2010-12-01       Impact factor: 11.361

3.  Inhibition of human CTL-mediated lysis by fibroblasts infected with herpes simplex virus.

Authors:  C M Posavad; J J Newton; K L Rosenthal
Journal:  J Immunol       Date:  1993-11-01       Impact factor: 5.422

4.  A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytes.

Authors:  I A York; C Roop; D W Andrews; S R Riddell; F L Graham; D C Johnson
Journal:  Cell       Date:  1994-05-20       Impact factor: 41.582

5.  Replication of herpes simplex virus in human T lymphocytes: characterization of the viral target cell.

Authors:  R W Braun; H K Teute; H Kirchner; K Munk
Journal:  J Immunol       Date:  1984-02       Impact factor: 5.422

6.  Site-specific Lys-63-linked tumor necrosis factor receptor-associated factor 6 auto-ubiquitination is a critical determinant of I kappa B kinase activation.

Authors:  Betty Lamothe; Arnaud Besse; Alejandro D Campos; William K Webster; Hao Wu; Bryant G Darnay
Journal:  J Biol Chem       Date:  2006-11-29       Impact factor: 5.157

7.  Infection and inhibition of human cytotoxic T lymphocytes by herpes simplex virus.

Authors:  C M Posavad; J J Newton; K L Rosenthal
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

8.  Herpes simplex virus-infected human fibroblasts are resistant to and inhibit cytotoxic T-lymphocyte activity.

Authors:  C M Posavad; K L Rosenthal
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

9.  Herpes simplex virus turns off the TAP to evade host immunity.

Authors:  A Hill; P Jugovic; I York; G Russ; J Bennink; J Yewdell; H Ploegh; D Johnson
Journal:  Nature       Date:  1995-06-01       Impact factor: 49.962

10.  Activation of ZAP-70 kinase activity by phosphorylation of tyrosine 493 is required for lymphocyte antigen receptor function.

Authors:  A C Chan; M Dalton; R Johnson; G H Kong; T Wang; R Thoma; T Kurosaki
Journal:  EMBO J       Date:  1995-06-01       Impact factor: 11.598

View more
  10 in total

Review 1.  Oncolytic herpes simplex virus interactions with the host immune system.

Authors:  Dipongkor Saha; Hiroaki Wakimoto; Samuel D Rabkin
Journal:  Curr Opin Virol       Date:  2016-08-03       Impact factor: 7.090

2.  HSV-1 Infection of Epithelial Dendritic Cells Is a Critical Strategy for Interfering with Antiviral Immunity.

Authors:  Yang Gao; Jishuai Cheng; Xingli Xu; Xueqi Li; Jingjing Zhang; Danjing Ma; Guorun Jiang; Yun Liao; Shengtao Fan; Zhenye Niu; Rong Yue; Penglan Chang; Fengyuan Zeng; Suqin Duan; Ziyan Meng; Xiangxiong Xu; Xinghang Li; Dandan Li; Li Yu; Lifen Ping; Heng Zhao; Mingtian Guo; Lichun Wang; Yafang Wang; Ying Zhang; Qihan Li
Journal:  Viruses       Date:  2022-05-14       Impact factor: 5.818

3.  Quantitative Trait Locus Based Virulence Determinant Mapping of the HSV-1 Genome in Murine Ocular Infection: Genes Involved in Viral Regulatory and Innate Immune Networks Contribute to Virulence.

Authors:  Aaron W Kolb; Kyubin Lee; Inna Larsen; Mark Craven; Curtis R Brandt
Journal:  PLoS Pathog       Date:  2016-03-10       Impact factor: 6.823

4.  US6 Gene Deletion in Herpes Simplex Virus Type 2 Enhances Dendritic Cell Function and T Cell Activation.

Authors:  Angello Retamal-Díaz; Kayla A Weiss; Eduardo I Tognarelli; Mariela Freire; Susan M Bueno; Betsy C Herold; William R Jacobs; Pablo A González
Journal:  Front Immunol       Date:  2017-11-10       Impact factor: 7.561

5.  A Herpes Simplex Virus Type 2 Deleted for Glycoprotein D Enables Dendritic Cells to Activate CD4+ and CD8+ T Cells.

Authors:  Angello R Retamal-Díaz; Alexis M Kalergis; Susan M Bueno; Pablo A González
Journal:  Front Immunol       Date:  2017-08-09       Impact factor: 7.561

Review 6.  Oncolytic herpes simplex virus and immunotherapy.

Authors:  Wenqing Ma; Hongbin He; Hongmei Wang
Journal:  BMC Immunol       Date:  2018-12-18       Impact factor: 3.615

Review 7.  Characteristics of herpes simplex virus infection and pathogenesis suggest a strategy for vaccine development.

Authors:  Xingli Xu; Ying Zhang; Qihan Li
Journal:  Rev Med Virol       Date:  2019-06-13       Impact factor: 6.989

8.  Functional paralysis of human natural killer cells by alphaherpesviruses.

Authors:  Tessa Mollie Campbell; Brian Patrick McSharry; Megan Steain; Tiffany Ann Russell; David Carl Tscharke; Jarrod John Kennedy; Barry Slobedman; Allison Abendroth
Journal:  PLoS Pathog       Date:  2019-06-13       Impact factor: 6.823

9.  An improved animal model for herpesvirus encephalitis in humans.

Authors:  Julia Sehl; Julia E Hölper; Barbara G Klupp; Christina Baumbach; Jens P Teifke; Thomas C Mettenleiter
Journal:  PLoS Pathog       Date:  2020-03-30       Impact factor: 6.823

10.  ThymicPeptides Reverse Immune Exhaustion in Patients with Reactivated Human Alphaherpesvirus1 Infections.

Authors:  Anna Hymos; Ewelina Grywalska; Janusz Klatka; Maria Klatka; Izabela Korona-Głowniak; Jacek Roliński
Journal:  Int J Mol Sci       Date:  2020-03-30       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.